APA (7th ed.) Citation

D, K., H, C., M, A., J, M., N, M., C, S., . . . O, H. (2026). Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer. NPJ precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01519-6

Chicago Style (17th ed.) Citation

D, Kim, et al. "Cyclin E1 Overexpression Identifies a Therapeutically Relevant Poor Prognostic Patient Subgroup in High-grade Serous Ovarian Cancer." NPJ Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01519-6.

MLA (9th ed.) Citation

D, Kim, et al. "Cyclin E1 Overexpression Identifies a Therapeutically Relevant Poor Prognostic Patient Subgroup in High-grade Serous Ovarian Cancer." NPJ Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01519-6.